Skip to main content
SpringerLink
Log in

Supra-oesophageal Manifestations of Gastro-oesophageal Reflux Disease

  • Review Article
  • Published:
Drugs Aims and scope Submit manuscript

Abstract

The extra-oesophageal signs that are most commonly related to gastro-oesophageal reflux include chest pain, asthma, chronic cough, posterior laryngitis and dental erosions. It is characteristic to find in such patients a poor presence of symptoms and endoscopic and pH-metric findings that are common in typical reflux. The therapeutic response to antisecretory drugs has become the most cost-effective tool for the diagnosis and treatment of this condition. Both the evidence available and expert agreement in consensus conferences support the use of proton pump inhibitors with doubled standard doses for at least 12 weeks in most cases. While an acceptable response is achieved with this significant acid inhibition, there are still questions to be answered in these and other aspects, such as the true prevalence, path physiology and diagnosis of this condition. It is therefore necessary and increasingly useful to create multidisciplinary teams with the aim to improve and promote understanding and the care of patients suffering from these supra-oesophageal symptoms caused by gastro-oesophageal reflux.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II
Table III
Fig. 1

Similar content being viewed by others

References

  1. Workshop consensus reports from the First Multidisciplinary International Symposium on supraesophageal complications of gastroesophageal reflux disease. Am J Med 1997; 103 Suppl 5A: 149S-50S.

  2. Edwards SJ, Lind T, Lundell L. Systematic review of proton pump inhibitors for the acute treatment of reflux esophagitis. Aliment Pharmacol Ther 2001; 15: 1729–36

    Article  PubMed  CAS  Google Scholar 

  3. Workshop consensus reports from the Second Multidisciplinary International Symposium on supraesophageal complications of gastroesophageal reflux disease. Am J Med 2000; 108 Suppl 4A: 170S-7S.

  4. Workshop consensus reports from the Third Multidisciplinary International Symposium on supraesophageal complications of gastroesophageal reflux disease. Am J Med 2001; 111 Suppl 1: 197S–201S.

    Google Scholar 

  5. Achem SR, Kolts BE, MacMath T, et al. Effects of omeprazole versus placebo in treatment of noncardiac chest pain and gastroesophageal reflux. Dig Dis Sci 1997; 42: 2138–45

    Article  PubMed  CAS  Google Scholar 

  6. Field SK, Sutherland LR. Does medical anti-reflux therapy improve asthma in asthmatics with gastroesophageal reflux? A critical review of the literature. Chest 1998; 114: 275–83

    Article  PubMed  CAS  Google Scholar 

  7. Coughlan JL, Gibson PG, Henry RL. Medical treatment for reflux esophagitis does not consistently improve asthma control: a systematic review. Thorax 2001; 56: 198–204

    Article  PubMed  CAS  Google Scholar 

  8. Meier JH, McNally PR, Punja M, et al. Does omeprazole (Prilosec) improve respiratory function in asthmatics with gastroesophageal reflux? A double-blind, placebo-controlled crossover study. Dig Dis Sci 1994; 39: 2127–33

    Article  PubMed  CAS  Google Scholar 

  9. Ford GA, Oliver PS, Prior JS, Butland RJ, Wilkinson SP. Omeprazole in the treatment of asthmatics with nocturnal symptoms and gastro-esophageal reflux: a placebo-controlled cross-over study. Postgrad Med J 1994; 70: 350–4

    Article  PubMed  CAS  Google Scholar 

  10. Teichtahl H, Kronborg IJ, Yeomans ND, et al. Adult asthma and gastro-esophageal reflux: the effects of omeprazole therapy on asthma. Aust NZ J Med 1996; 26: 671–6

    Article  CAS  Google Scholar 

  11. Harding SM, Richter JE, Guzzo MR, et al. Asthma and gastroesophageal reflux: acid suppressive therapy improves asthma outcome. Am J Med 1996; 100: 395–405

    Article  PubMed  CAS  Google Scholar 

  12. Levin TR, Sperling RM, McQuaid KR. Omeprazole improves peak expiratory flow rate and quality of life in asthmatics with gastroesophageal reflux. Am J Gastro-enterol 1998; 93: 1060–3

    Article  CAS  Google Scholar 

  13. Boeree MJ, Peters FT, Postma DS, et al. No effects of high-dose omeprazole in patients with severe airway hyperre-sponsiveness and (a)symptomatic gastro-esophageal reflux. Eur Respir J 1998; 11: 1070–4

    Article  PubMed  CAS  Google Scholar 

  14. Kiljander TO, Salomaa ER, Hietanen EK, et al. Gastroesophageal reflux in asthmatics: a double-blind, placebo-controlled, crossover study with omeprazole. Chest 1999; 116: 1257–64

    Article  PubMed  CAS  Google Scholar 

  15. Ours T, Kavuru M, Schilz R, et al. A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough. Am J Gastroenterol 1999; 94: 3131–8

    Article  PubMed  CAS  Google Scholar 

  16. Kiljander TO, Salomaa ER, Hietanen EK, et al. Chronic cough and gastro-esophageal reflux: a double-blind placebo-controlled study with omeprazole. Eur Respir J 2000; 16: 633–8

    Article  PubMed  CAS  Google Scholar 

  17. Irwin RS, Curley FJ, French CL. Chronic cough: the spectrum and frequency of causes, key components of the diagnostic evaluation, and outcome of specific therapy. Am Rev Respir Dis 1990; 141: 640–7

    Article  PubMed  CAS  Google Scholar 

  18. Irwin RS, Zawacki JK, Curley FJ, et al. Chronic cough as the sole presenting manifestation of gastroesophageal reflux. Am Rev Respir Dis 1989;1294-300

  19. Irwin RS, French CL, Curley FJ, et al. Chronic cough due to gastroesophageal reflux: clinical, diagnostic, and patho-genetic aspects. Chest 1993; 104: 1511–7

    Article  PubMed  CAS  Google Scholar 

  20. Koufman JA. The otolaryngologic manifestations of gastro-esophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laringoscope 1991; 101: 1–78

    Article  CAS  Google Scholar 

  21. Kamel PL, Hanson D, Kahrilas PJ. Omeprazole for the treatment of posterior laryngitis. Am J Med 1994; 96: 321–6

    Article  PubMed  CAS  Google Scholar 

  22. Hanson DG, Kamel PL, Kahrilas PJ. Outcome of antireflux therapy for the treatment of chronic laryngitis. Ann Otol Rhinol Laryngol 1995; 104: 550–5

    PubMed  CAS  Google Scholar 

  23. Shaw GY, Searl JP, Young JL, et al. Subjective, laryngo-scopic, and acoustic measurements of laryngeal reflux before and after treatment with omeprazole. J Voice 1996; 10: 410–8

    Article  PubMed  CAS  Google Scholar 

  24. Wo JM, Grist WJ, Gussack G, et al. Empiric trial of high-dose omeprazole in patients with posterior laryngitis: a prospective study. Am J Gastroenterol 1997; 92: 2160–5

    PubMed  CAS  Google Scholar 

  25. Metz DC, Childs ML, Ruiz C, et al. Pilot study of the oral omeprazole test for reflux laryngitis. Otolaryngol Head Neck Surg 1997; 116: 41–6

    Article  PubMed  CAS  Google Scholar 

  26. Vaezi MF, Hicks DM, Ours TM, et al. ENT manifestations of GERD: a large prospective study assessing treatment outcome and predictors of response [Abstract]. Gastro-enterology 2001; 120: A636

    Google Scholar 

  27. Rodriguez-Tellez M, Galera-Ruiz H, Arguelles-Arias F, et al. Posterior laryngitis: effects of treatment with omeprazole alone. Rev Esp Enferm Dig 2002; 94: 123–30

    PubMed  CAS  Google Scholar 

  28. Garrigues V, Gisbert L, Bastida G, et al. Manifestations of gastroesophageal reflux and response to omeprazole therapy in patients with chronic posterior laryngitis: an evaluation based on clinical practice. Dig Dis Sci 2003; 48: 2117–23

    Article  PubMed  CAS  Google Scholar 

  29. DelGaudio JM, Waring P. Empiric esomeprazole in the treatment of laryngopharyngeal reflux. Laryngoscope 2003; 113: 598–601

    Article  PubMed  CAS  Google Scholar 

  30. Williams RB, Szczesniak MM, Maclean JC, et al. Predictors of outcome in an open label, therapeutic trial of high-dose omeprazole in laryngitis. Am J Gastroenterol 2004; 99: 777–85

    Article  PubMed  CAS  Google Scholar 

  31. Havas T, Huang S, Levy M, et al. Posterior pharyngolaryngitis. Double-blind randomised placebo-controlled trial of proton pump inhibitor therapy. Aus J Otolaryngol 1999; 3: 243–6

    Google Scholar 

  32. El-Serag HB, Lee P, Buchner A, et al. Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial. Am J Gastroenterol 2001; 96: 979–83

    Article  PubMed  CAS  Google Scholar 

  33. Noordzij JP, Khidr A, Evans BA, et al. Evaluation of omeprazole in the treatment of reflux laryngitis: a prospective, placebo-controlled, randomized, double-blind study. Laryngoscope 2001; 111: 2147–51

    Article  PubMed  CAS  Google Scholar 

  34. Eherer AJ, Habermann W, Hammer HF, et al. Effect of pantoprazole on the course of reflux-associated laryngitis: a placebo-controlled double-blind crossover study. Scand J Gastroenterol 2003; 38: 462–7

    Article  PubMed  CAS  Google Scholar 

  35. Vaezi M, Richter JE, Stasney CR, et al. A randomised, double-blind, placebo-controlled study of acid suppression for the treatment of suspected laryngopharyngeal reflux [Abstract]. Gastroenterology 2004; 126: A22

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Gastroenterology Service, “Virgen Macarena” University Hospital, C/Dr. Redrinni 3, 41071, Seville, Spain

    Manuel Rodríguez-Téllez (Associate Physician)

Authors
  1. Manuel Rodríguez-Téllez
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Manuel Rodríguez-Téllez.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rodríguez-Téllez, M. Supra-oesophageal Manifestations of Gastro-oesophageal Reflux Disease. Drugs 65 (Suppl 1), 67–73 (2005). https://doi.org/10.2165/00003495-200565001-00010

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-200565001-00010

Keywords

Search

Navigation